Natriuretic peptides - Update on peptide release, bioactivity, and clinical use

被引：37

作者：

Richards, A. Mark ^{[1
]}

机构：

[1] Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Med, Natl Heart Fdn New Zealand, Christchurch, New Zealand

来源：

HYPERTENSION | 2007年 / 50卷 / 01期

关键词：

D O I：

10.1161/HYPERTENSIONAHA.106.069153

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

[No abstract available]

引用

页码：25 / 30

页数：6

共 44 条

[1] Sphingosine-1-phosphate inhibits C-type natriuretic peptide activation of guanylyl cyclase B (GC-B/NPR-B) [J].

Abbey-Hosch, SE ;

Cody, AN ;

Potter, LR .

HYPERTENSION, 2004, 43 (05) :1103-1109

[2] Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease [J].

Campbell, DJ ;

Woodward, M ;

Chalmers, JP ;

Colman, SA ;

Jenkins, AJ ;

Kemp, BE ;

Neal, BC ;

Patel, A ;

MacMahon, SW .

HYPERTENSION, 2005, 45 (01) :69-74

[3] Sgk1 mediates osmotic induction of NPR-A gene in rat inner medullary collecting duct cells [J].

Chen, SC ;

McCormick, JA ;

Prabaker, K ;

Wang, J ;

Pearce, D ;

Gardner, DG .

HYPERTENSION, 2004, 43 (04) :866-871

[4] Cyclophilin a functions as an endogenous inhibitor for membrane-bound guanylate cyclase-A [J].

Chen, ZJ ;

Vetter, M ;

Chang, GD ;

Liu, SG ;

Che, DN ;

Ding, YX ;

Kim, SS ;

Chang, CH .

HYPERTENSION, 2004, 44 (06) :963-968

[5] Reciprocal antagonism coordinates C-type natriuretic peptide and mitogen-signaling pathways in fibroblasts [J].

Chrisman, TD ;

Garbers, DL .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) :4293-4299

[6] Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling [J].

Franco, V ;

Chen, YF ;

Oparil, S ;

Feng, JA ;

Wang, DJ ;

Hage, F ;

Perry, G .

HYPERTENSION, 2004, 44 (05) :746-750

[7] Attenuation of lysophosphatidylcholine-induced suppression of ANP release from hypertrophied atria [J].

Han, JH ;

Cao, CH ;

Kim, SM ;

Piao, FL ;

Kim, SH .

HYPERTENSION, 2004, 43 (02) :243-248

[8] Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction [J].

Hayashi, M ;

Tsutamoto, T ;

Wada, A ;

Maeda, K ;

Mabuchi, N ;

Tsutsui, T ;

Horie, H ;

Ohnishi, M ;

Kinoshita, M .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (07) :1820-1826

[9] Interleukin-1β regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes [J].

He, Q ;

LaPointe, MC .

HYPERTENSION, 1999, 33 (01) :283-289

[10] Characterization of a cGMP-response element in the guanylyl cyclase/natriuretic peptide receptor a gene promoter [J].

Hum, D ;

Besnard, S ;

Sanchez, R ;

Devost, D ;

Gossard, F ;

Hamet, P ;

Tremblay, J .

HYPERTENSION, 2004, 43 (06) :1270-1278

← 1 2 3 4 5 →